Evaxion Biotech (EVAX) has released an update.
Evaxion Biotech has announced that its board of directors is authorized to issue warrants and increase the company’s share capital until April 2029. This strategic move enables key employees and board members to acquire shares, potentially impacting the company’s financial trajectory and stock market performance.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.
